Dr. Harman Singh Kular, MD

Dr. Kular practices at Houston Methodist Cypress Hospital in Cypress, Texas, part of Houston Methodist.

Dr. Kular's NPI, 1003173550, was assigned on April 20, 2012. Dr. Kular graduated from Baylor College Of Medicine in 2012. Dr. Kular holds Texas license R6034.

Dr. Kular's primary practice is Houston Methodist Cypress Hospital, at 24500 Northwest Fwy, Cypress, TX 77429 in Harris County. The practice phone is (346) 618-1506.

Dr. Kular's primary practice is Houston Methodist Cypress Hospital in Cypress, Texas, part of Houston Methodist. Dr. Kular is also affiliated with Memorial Hermann-Texas Medical Center. The medical group on file is Texas Multi-Specialty Group. Dmand AI also links Dr. Kular to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kular practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kular's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Kular is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Kular is licensed in Texas.

Dmand AI lists asthma, bronchitis, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pneumonia, sleep apnea and tobacco use among the conditions Dr. Kular treats.

CMS data shows 1,489 Medicare services from Dr. Kular across 9 procedure codes in 2024, for 540 Medicare patients. Medicare paid $145,443 for them.

CMS counts 540 Medicare patients who saw Dr. Kular in 2024. The largest group is 75 to 84, with 199 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 3.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kular's median patient age at 68, with 50% women.

In 2024, Dr. Kular wrote 556 Medicare Part D claims for 131 patients. 67% of them were for generic drugs. CMS names the drug for 453 of them, across 14 drugs with 11 or more claims each, at $45,232 in total drug cost. In 2023, CMS named 317 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kular for performance year 2024, reported as part of a group. Dr. Kular accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Kular. Dr. Kular's most frequent co-authors are Roberto Fernando Casal, MD, Lorraine Cornwell, MD and Donald Ray Lazarus, MD.

Dmand AI links Dr. Kular to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 113 general payments to Dr. Kular from 33 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $595.

Dr. Kular graduated from Baylor College Of Medicine in 2012.

Dr. Kular is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.